You do not have permission to access this chart.
Please Sign Up or Login

About:

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD 201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also develops drugs for the treatment of pain, inflammation, and neurological disorders. It has license agreements with Epitech Group SpA.; and with Innovet Italia S.R.L. to develop veterinary drugs for the treatment of gastro-intestinal diseases in dogs and cats. The company was founded in 1998 and is headquartered in Toronto, Canada.

Sector:

Healthcare

Industry:

Drug Manufacturers—Specialty & Generic

Employees:

9

Address:

FSD Pharma Inc. First Canadian Place Suite 3400 100 King Street West Toronto ON M5X 1A4 Canada

Website:

http://www.fsdpharma.com

Phone:

416-854-8884

Leave a comment

Your email address will not be published. Required fields are marked *